4158 studies found for:    Open Studies | "Communicable Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Communicable Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Detection and Characterization of Infections and Infection Susceptibility
Conditions: Immune Disorders;   Chronic Granulomatous Disease;   Genetic Immunological Deficiencies;   Hyperimmunoglobulin-E Recurrent Infection Syndrome;   Recurrent Infections;   Unknown Immune Deficiency;   GATA2 Deficiency (MonoMAC),;   Nontuberculous Mycobacterial Infections;   Hyper IgE (Job s) Syndrome;   Leukocyte Adhesion Deficiency;   Susceptibility to Disseminated Infections;   Primary Immune Deficiency Disease (PIDD)
Intervention:
2 Recruiting Oral Human Papillomavirus Infection in HIV-infected Men
Conditions: Papillomavirus Infections;   HIV Infections
Intervention: Procedure: Oral swabs for HPV-typing and high-risk HPV-determination
3 Unknown  Infections Caused by ESbL-Producing Enterobacteriaceae in Italy
Conditions: Enterobacteriaceae Infections;   Bacteremia;   Pneumonia;   Skin Diseases;   Urinary Tract Infections
Interventions: Behavioral: Risk factors for infections due to ESBL+ Enterobacteriaceae;   Behavioral: Risk factors for inadequate initial antimicrobial therapy;   Behavioral: Overall and 30-day mortality in bad first antibiotic therapy
4 Recruiting Randomized, Multicenter, Double-blind, Vancomycin-controlled Study to Evaluate the Efficacy of Ethanol Lock Solution for the Curative Treatment of Implantable Venous Access Port Infection Due to Coagulase-negative Staphylococci
Conditions: Lock Solution;   Catheter Related Blood Stream Infections;   Central Venous Catheter Infection;   Intravenous Drug Delivery Systems;   Coagulase-negative Staphylococci Infection
Interventions: Drug: Ethanol 40% + Enoxaparine 400UI/ml;   Drug: Vancomycine 5 mg/ml + Héparine 2500UI/ml
5 Recruiting Optimizing Prevention of Healthcare-Acquired Infections After Cardiac Surgery (HAI)_2
Conditions: Cardiovascular Disease;   Healthcare Associated Infectious Disease;   Sternal Superficial Wound Infection;   Deep Sternal Infection;   Mediastinitis;   Thoracotomy;   Conduit Harvest or Cannulation Site;   Sepsis;   Pneumonia
Intervention: Other: There is no intervention. The investigators are interviewing cardiac surgery staff with knowledge of infection prevention.
6 Unknown  Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infection
Conditions: Latent Tuberculosis Infection;   HIV Infections;   Tuberculosis
Intervention:
7 Unknown  A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes
Conditions: Anemia;   Intestinal Helminthiasis;   Intestinal Schistosomiasis;   Human Immunodeficiency Virus I Infection;   Hematologic Diseases;   Opportunistic Infections
Intervention: Drug: Praziquantel and Albendazole
8 Recruiting Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection
Conditions: Acute HIV Infection;   HIV Infections
Intervention: Drug: Telmisartan
9 Available Direct Antibiotic Delivery of Cefazolin Into Soft Tissue Infections Using Subcutaneous Injection and Ultrasonic Dispersion
Conditions: Infection, Soft Tissue;   Infection, Wound;   Cellulitis;   Foot Ulcer, Diabetes
Interventions: Drug: Cefazolin;   Device: Silberg Tissue Preparation System
10 Unknown  Surveillance for Nosocomial Infections in Pediatric Cancer Patients
Conditions: Nosocomial Infections;   Bloodstream Infection;   Invasive Aspergillosis
Intervention:
11 Available Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)
Conditions: EBV Infection;   CMV Infection;   Adenoviral Infection
Intervention: Biological: Trivirus-Specific CTLs
12 Unknown  Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infection
Conditions: HIV Infections;   Liver Toxicity;   Hepatitis Co-infection
Intervention:
13 Recruiting Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporineversus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A
Conditions: Transplantation Infection;   Cytomegalovirus Infection
Interventions: Drug: Everolimus;   Drug: mycophenolic acid
14 Recruiting Study of Antibiotic Spacer Design to Treat Infection After Hip Replacement
Conditions: Osteoarthritis;   Hip Infection;   Prosthetic Joint Infection;   Complications; Arthroplasty, Infection or Inflammation;   Complications; Arthroplasty
Interventions: Procedure: Implantation of a static, non-articulating cement spacer.;   Procedure: Implantation of an articulating spacer.
15 Recruiting Articulating Versus Static Antibiotic Loaded Spacers for the Treatment of Prosthetic Knee Infection
Conditions: Osteoarthritis;   Knee Infection;   Prosthetic Joint Infection;   Complications; Arthroplasty, Infection or Inflammation;   Complications; Arthroplasty
Interventions: Procedure: Static Spacer;   Procedure: Articulating Spacer
16 Recruiting Study of Mycobacterial Infections
Conditions: Atypical Mycobacterium Infections;   Cystic Fibrosis;   Job's Syndrome
Intervention:
17 Recruiting STRIPES Study: Study To Reduce Infection Post cEsarean Section
Conditions: Chlorhexidine Gluconate Cloths;   Infection; Cesarean Section;   Infectious Morbidity;   Surgical Site Infections;   Endometritis
Interventions: Device: 2% chlorhexidine gluconate (CHG) cloth;   Device: Placebo cloth
18 Unknown  HIV-HBV Co-Infection and Liver Disease
Conditions: HIV Infections;   HIV-HBV Co-Infection
Intervention:
19 Not yet recruiting Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From Ghana
Conditions: Mansonella Perstans Infection;   Buruli Ulcer;   Tuberculosis;   Co-infection
Intervention: Drug: Doxycycline
20 Unknown  Hospital Design and Risk of Nosocomial Infections: A Prospective Controlled Trial
Conditions: Hospital-Acquired Infection With Clostridium Difficile;   Hospital-Acquired VRE Infection or Colonization;   Hospital-Acquired MRSA Infection or Colonization
Intervention: Other: Admission to a novel hospital ward

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years